With two decades of leadership in glaucoma research and translational science, Dr. Steel will shape the Foundation's scientific strategy and accelerate innovation ... .
... and Technology innovation businesses, successfully completed a search assignment for Biomia and is pleased to announce the placement of Frederick Westhorpe, PhD as Chief Scientific Officer (CSO).
Seasoned executive brings more than three decades of immunotherapy and drug discovery experience. Seasoned executive brings more than three decades of immunotherapy and drug discovery experience ... .